<DOC>
	<DOC>NCT00234910</DOC>
	<brief_summary>The purpose of this study is to obtain a preliminary assessment of the antiviral activity and tolerability of simplified Kaletra dual agent therapy as initial treatment for HIV infection, relative to a Kaletra three drug standard of care reference arm.</brief_summary>
	<brief_title>Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Lopinavir</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<criteria>HIV positive &gt;18 years of age HIV RNA&gt; 400 copies/mL Any CD 4 cell count Antiretroviral naïve No acute illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>Lopinavir</keyword>
	<keyword>Ritonavir</keyword>
	<keyword>Kaletra</keyword>
	<keyword>Tenofovir</keyword>
	<keyword>HIV infection</keyword>
	<keyword>Treatment Naive</keyword>
</DOC>